Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Kendan A/S
A/S
Dissolved
CVR 13252009
Vassingerød Bygade 6, 3540
Lynge
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1989 · 37 years old
11 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Kendan A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
26M
20M
13M
7M
0M
2012: 16M
16M
2012
2013: 17M (+6% vs 2012)
17M
+6%
2013
2014: 21M (+24% vs 2013)
21M
+24%
2014
EBITDA
DKK millions
7M
6M
4M
2M
0M
2012: 6M
6M
2012
2013: 6M (0% vs 2012)
6M
0%
2013
2014: 6M (0% vs 2013)
6M
0%
2014
Income statement
DKK thousands
Item
2014
2013
2012
Gross profit
20.627
17.362
16.212
Staff expenses
-14.422
-10.998
-10.218
EBITDA
6.205
6.363
5.994
Depreciation & amort.
-1.111
-682
678
EBIT
5.094
5.681
5.316
Net financials
412
-134
-428
Profit before tax
5.505
5.547
4.888
Tax
1.386
1.405
1.280
Net profit
4.119
4.142
3.609
Balance sheet
DKK thousands
Item
2014
2013
2012
Total assets
22.502
21.969
25.964
Equity
11.860
10.241
8.098
Long-term debt
0
789
1.375
Short-term debt
10.643
10.897
16.464
Total debt
10.643
11.686
17.839
Financial ratios
5-year trend
EBITDA margin (of gross profit)
30,1 %
This company
2012
2014
Equity ratio
52,7 %
This company
38,2 %
Market median
This company
Market median
38% above market
2012
2014
Return on equity
34,7 %
This company
18,4 %
Market median
This company
Market median
89% above market
2012
2014
Net profit margin (of gross profit)
20,0 %
This company
2012
2014
Asset turnover (of gross profit)
0,92×
This company
2012
2014
Debt / equity
0,90×
This company
0,62×
Market median
This company
Market median
45% above market
2012
2014
Annual reports & filings
Annual report 2014
Filed via CVR / Virk · Period 2013-07-01 – 2014-12-31
View
PDF
Annual report 2013
Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
View
PDF
Annual report 2012
Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
View
PDF
More on Kendan A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
